Management of Gestational Trophoblastic Disease

Gynecologic Cancer: Controversies in Management

Volumn , Issue , 2004, Pages 555-574

  Seckl, Michael J ^a,b   Newlands, Edward S ^a,b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745881825     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-07142-3.50048-8     Document Type: Chapter

References (139)

1. WB Ober and RO Fass (1961) The early history of choriocarcinoma. Ann N Y Acad Sci 172 299-426.
2. UW Mueller, CS Hawes, AE Wright, et al. (1990) Isolation of fetal trophoblast cells from peripheral blood of pregnant women. Lancet 336 197-200.
3. WHO (1983) Gestational trophoblastic diseases. Technical report series 692 Geneva: World Health Organization 7-81.
4. T Kajii and K Ohama (1977) Androgenetic origin of hydatidiform mole. Nature 268 633-634.
5. P Vassilakos, G Riotton and T Kajii (1977) Hydatidiform mole: Two entities. A morphologic and cytogenic study with some clinical considerations. Am J Obstet Gynecol 127 167-170.
6. SD Lawler, VG Pickthall, RA Fisher, et al. (1979) Genetic studies of complete and partial hydatidiform mole [letter]. Lancet 2 580.
7. SD Lawler, S Povey, RA Fisher and VG Pickthall (1982) Genetic studies on hydatidiform moles, II. The origin of complete moles. Ann Hum Genet 46 209-222.
8. PA Jacobs, CM Wilson, JA Sprenkle, et al. (1980) Mechanism of origin of complete hydatidiform mole. Nature 286 714-716.
9. JR Davis, EA Surwit, JP Garay and KJ Fortier (1984) Sex assignment in gestational trophoblastic neoplasia. Am J Obstet Gynecol 148 722-725.
10. K Ohama, T Kajii, E Okamoto, et al. (1981) Dispermic origin of XY hydatidiform mole. Nature 292 551-552.
11. RA Fisher, S Povey, AJ Jeffreys, et al. (1989) Frequency of heterozygous complete hydatidiform moles, estimated by locus-specific minisatellite and Y chromosome-specific probes. Hum Genet 82 259-263.
12. RA Fisher and ES Newlands (1998) Gestational trophoblastic disease: Molecular and genetic studies. J Reprod Med 43 81-97.
13. F Paradinas (1994) The histological diagnosis of hydatidiform moles. Curr Diagn Pathol 1 24-31.
14. FJ Paradinas, P Browne, RA Fisher, et al. (1996) A clinical, histopatho-logical and flow cytometric study of 149 complete moles, 146 partial moles and 107 non-molar hydropic abortions. Histopathology 28 101-110.
15. FJ Paradinas, RA Fisher, P Browne and ES Newlands (1997) Diploid hydatidiform moles with fetal red blood cells in molar villi. I. Pathology, incidence and prognosis. J Pathol 181 183-188.
16. FJ Paradinas (1998) The diagnosis and prognosis of molar pregnancy. The experience of the National Referral Centre in London. Int J Gynaecol Obstet 60 S57-S64.
17. DH Castrillon, D Sun, S Weremowicz, et al. (2001) Discrimination of complete hydatidiform mole from its mimics by immunohisto-chemistry of the paternally imprinted gene product p57KIP2. Am J Surg Pathol 25 1225-1230.
18. DR Genest, RE Ruiz, S Weremowicz, et al. (2002) Do nontriploid partial hydatidiform moles exist? A histologic and flow cytometric reevaluation of nontriploid specimens. J Reprod Med 47 363-368.
19. PA Jacobs, PA Hunt, JS Matsuuro and CC Wilson (1982) Complete and partial hydatidiform mole in Hawaii: Cytogenetics, morphology and epidemiology. Br J Obstet Gynaecol 89 258-266.
20. SD Lawler, RA Fisher, VG Pickthall, et al. (1982) Genetic studies on hydatidiform moles. I. The origin of partial moles. Cancer Genet Cytogenet 4 309-320.
21. MJ Seckl, RA Fisher, GA Salerno, et al. (2000) Choriocarcinoma and partial hydatidiform moles. Lancet 356 36-39.
22. FJ Paradinas, NJ Sebire, RA Fisher, et al. (2001) Pseudo-partial moles: Placental stem vessel hydrops and the association with Beckwith-Wiedemann syndrome and complete moles. Histo-pathology 39 447-454.
23. T Arima, T Imamura, S Amada, et al. (1994) Genetic origin of malignant trophoblastic neoplasms. Cancer Genet Cytogenet 73 95-102.
24. N Wake, K-I Tanaka, V Chapman, et al. (1981) Chromosomes and cellular origin of choriocarcinoma. Cancer Res 41 3137-3143.
25. RSK Chaganti, PRK Kodura, R Chakraborty, et al. (1990) Genetic origin of trophoblastic choriocarcinoma. Cancer Res 50 6330-6333.
26. H Osada, M Kawata, M Yamada, et al. (1991) Genetic identification of pregnancies responsible for choriocarcinomas after multiple pregnancies by restriction fragment length polymorphism analysis. Am J Obstet Gynaecol 165 682-688.
27. RA Fisher, ES Newlands, AJ Jeffreys, et al. (1992) Gestational and non-gestational trophoblastic tumours distinguished by DNA analysis. Cancer 69 839-845.
28. RA Fisher, SD Lawler, S Povey and KD Bagshawe (1988) Genetically homozygous choriocarcinoma following pregnancy with hydatidiform mole. Br J Cancer 58 788-892.
29. RA Fisher, BA Soteriou, L Meredith, et al. (1995) Previous hydatidiform mole identified as the causative pregnancy of choriocarcinoma following birth of normal twins. Int J Cancer 5 64-70.
30. ES Newlands, M Bower, RA Fisher and FJ Paradinas (1998) Management of placental site trophoblastic tumours. J Reprod Med 43 53-59.
31. IM Shih and RJ Kurman (1998) Ki-67 labelling index in the differential diagnosis of exaggerated placental site, placental site trophoblastic tumour, and choriocarcinoma: A double staining technique using Ki-67 and Mel-CAM antibodies. Hum Pathol 29 27-33.
32. CM Feltmate, DR Genest, L Wise, et al. (2001) Placental site trophoblastic tumor: A 17-year experience at the New England Trophoblastic Disease Center. Gynecol Oncol 82 415-419.
33. AJ Papadopoulos, M Foskett, MJ Seckl, et al. (2002) Twenty-five years' clinical experience of placental site trophoblastic tumors. J Reprod Med 47 460-464.
34. Y Hao, T Crenshaw, T Moulton, et al. (1993) Tumor suppressor activity of H19 RNA. Nature 365 764-767.
35. S Matsuoka, JS Thompson, MC Edwards, et al. (1996) Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57kip2, on chromosome 11p15. Proc Natl Acad Sci U S A 93 3026-3030.
36. O Ogawa, MR Eccles, J Szeto, et al. (1993) Relaxation in insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 362 749-751.
37. M Chilosi, E Piazzola, M Lestani, et al. (1998) Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Invest 78 269-276.
38. C Walsh, SJ Miller, F Flam, et al. (1995) Paternally derived H19 is differentially expressed in malignant and non-malignant trophoblast. Cancer Res 55 1111-1116.
39. K Hashimoto, C Azuma, M Koyama, et al. (1995) Loss of imprinting in choriocarcinoma. Nat Genet 9 109-110.
40. YB Moglabey, R Kircheisen, M Seoud, et al. (1999) Genetic mapping of a maternal locus responsible for familial hydatidiform moles. Hum Mol Genet 8 667-671.
41. H Judson, BE Hayward, E Sheridan and DT Bonthron (2002) A global disorder of imprinting in the human female germ line. Nature 416 539-542.
42. LA Cole (1998) hCG, its free subunits and its metabolites. Roles in pregnancy and trophoblastic disease. J Reprod Med 43 3-10.
43. S Birken, A Krichevsky, J O'Connor, et al. (1999) Development and characterization of antibodies to a nicked and hyperglycosylated form of a hCG from a choriocarcinoma patient: Generation of antibodies that differentiate between pregnancy hCG and choriocarcinoma hCG. Endocrine 10 137-144.
44. S Birken, G Kovalevskaya and J O'Connor (2001) Immunochemical measurement of early pregnancy isoforms of HCG: Potential applications to fertility research, prenatal diagnosis, and cancer. Arch Med Res 32 635-643.
45. LA Cole, S Shahabi, SA Butler, et al. (2001) Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases. Clin Chem 47 308-315.
46. S Rotmensch and LA Cole (2000) False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations. Lancet 355 712-715.
47. JL Vaitukaitis (1979) Human chorionic gonadotrophin-a hormone secreted for many reasons. N Engl J Med 301 324-326.
48. KD Bagshawe (1976) Risk and prognostic factors in trophoblastic neoplasia. Cancer 38 1373-1385.
49. R Agarwal, S Strickland, IA McNeish, et al. (2002) Doppler ultrasonog-raphy of the uterine artery and the response to chemotherapy in patients with gestational trophoblastic tumors. Clin Cancer Res 8 1142-1147.
50. EI Kohorn (2002) Persistent low-level “real” human chorionic gonadotropin: A clinical challenge and a therapeutic dilemma. Gynecol Oncol 85 315-320.
51. RS Berkowitz and DP Goldstein (1981) Pathogenesis of gestational trophoblastic neoplasms. Pathol Annu 11 391-411.
52. CB Benson, DR Genest, MR Bernstein, et al. (2000) Sonographic appearance of first trimester complete hydatidiform moles. Ultrasound Obstet Gynecol 16 188-191.
53. NJ Sebire, H Rees, F Paradinas, et al. (2001) The diagnostic implications of routine ultrasound examination in histologically confirmed early molar pregnancies. Ultrasound Obstet Gynecol 18 662-665.
54. DP Goldstein and RS Berkowitz (1994) Current management of complete and partial molar pregnancy. J Reprod Med 39 139-146.
55. NJ Sebire, M Foskett, FJ Paradinas, et al. (2002) Outcome of twin pregnancies with complete hydatidiform mole and healthy co-twin. Lancet 359 2165-2166.
56. MJ Seckl, GJS Rustin, ES Newlands, et al. (1991) Pulmonary embolism, pulmonary hypertension, and choriocarcinoma. Lancet 338 1313-1315.
57. JH Tidy, GJS Rustin, ES Newlands, et al. (1995) Presentation and management of choriocarcinoma after nonmolar pregnancy. Br J Obstet Gynaecol 102 715-719.
58. P Savage, M Roddie and MJ Seckl (1998) A 28-year-old woman with a pulmonary embolus. Lancet 352 30.
59. S Kishkuno, A Ishida, Y Takahashi, et al. (1997) A case of neonatal choriocarcinoma. Am J Perineonatol 14 79-82.
60. KD Bagshawe and MIM Noble (1965) Cardiorespiratory effects of trophoblastic tumours. Q J Med 137 39-54.
61. HY Ngan, FL Chan, VW Au, et al. (1998) Clinical outcome of micrometastasis in the lung in stage IA persistent gestational trophoblastic disease. Gynecol Oncol 70 192-194.
62. JE Boultebee and ES Newlands (1995) New diagnostic and therapeutic approaches to gestational trophoblastic tumours. TH Bourne, E Jauniaux, D Jurkovic (Eds) Transvaginal Colour Doppler. The Scientific Basis and Practical Application of Colour Doppler in Gynaecology New York: Springer 57-65.
63. AKP Lim, R Agarwal, N Barrett, et al. (2002) Embolization of residual uterine vascular malformations in patients with gestational trophoblastic tumours. Radiology 222 640-644.
64. RHJ Begent, KD Bagshawe, AJ Green and AJ Searle (1987) The clinical value of imaging with antibody to human chorionic gonadotrophin in the detection of residual choriocarcinoma. Br J Cancer 55 657-660.
65. H Hebart, C Erley, B Kaskas, et al. (1996) Positron emission tomography helps to diagnose tumor emboli and residual disease in choriocarcinoma. Ann Oncol 7 416-418.
66. G Beets, F Penninckx, C Schiepers, et al. (1994) Clinical value of whole body positron emission tomography with [ 18F]fluorodeoxyglucose in recurrent colorectal cancer. Br J Surg 81 1666-1670.
67. KD Bagshawe, J Dent and J Webb (1986) Hydatidiform mole in the United Kingdom, 1973-1983. Lancet 2 673.
68. JA Tidy, AM Gillespie, N Bright, et al. (2000) Gestational trophoblastic disease: A study of mode of evacuation and subsequent need for treatment with chemotherapy. Gynecol Oncol 78(Pt 1), 309-312.
69. H Matsui, Y Iitsuka, J Ishii, et al. (1999) Androgenetic complete mole coexistent with a twin live fetus. Gynecol Oncol 74 217-221.
70. H Matsui, S Sekiya, T Hando, et al. (2000) Hydatidiform mole coexistent with a twin live fetus: A national collaborative study in Japan. Hum Reprod 15 608-611.
71. MA Steller, DR Genest, MR Bernstein, et al. (1994) Natural history of twin pregnancy with complete hydatidiform mole and coexisting fetus. Obstet Gynecol 83 35-42.
72. HR Franke, EK Risse, P Kenemans, et al. (1983) Plasma human chorionic gonadotropin disappearance in hydatidiform mole: A central registry report from the Netherlands. Obstet Gynecol 62 467-473.
73. BH Martin and JH Kim (1998) Changing face of gestational trophoblastic disease. Int J Gynaecol Oncol 60 S111-S120.
74. M Stone, J Dent, A Kardana and KD Bagshawe (1976) Relationship of oral contraceptive to development of trophoblastic tumour after evacuation of hydatidiform mole. Br J Obstet Gynaecol 86 913-916.
75. RE Deicas, DS Miller, AW Rademaker and JR Lurain (1991) The role of contraception in the development of postmolar gestational trophoblastic tumor. Obstet Gynecol 78 221-226.
76. JR Palmer, SG Driscoll, L Rosenberg, et al. (1999) Oral contraceptive use and risk of gestational trophoblastic tumors. J Natl Cancer Inst 91 635-640.
77. EI Kohorn (2001) The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: Description and critical assessment. Int J Gynaecol Cancer 11 73-77.
78. GJS Rustin, ES Newlands, J-M Lutz, et al. (1996) Combination but not single agent methotrexate chemotherapy for gestational trophoblastic tumours (GTT) increases the incidence of second tumours. J Clin Oncol 14 2769-2773.
79. M Bower, ES Newlands, L Holden, et al. (1997) EMA/CO for high-risk gestational trophoblastic tumours: Results from a cohort of 272 patients. J Clin Oncol 15 2636-2643.
80. IA McNeish, S Strickland, L Holden, et al. (2002) Low risk persistent gestational trophoblastic disease: Outcome following initial treatment with low-dose methotrexate and folinic acid, 1992-2000. J Clin Oncol 20 1838-1844.
81. RS Berkowitz, DP Goldstein and MR Bernstein (1986) Ten years' experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease. Gynecol Oncol 23 111-118.
82. JR Lurain and EP Elfstrand (1995) Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors. Am J Obstet Gynecol 172(Pt 1), 574-579.
83. LC Wong, HY Ngan, DK Cheng and TY Ng (2000) Methotrexate infusion in low-risk gestational trophoblastic disease. Am J Obstet Gynecol 183 1579-1582.
84. JS Kwon, L Elit, J Mazurka, et al. (2001) Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia. Gynecol Oncol 82 367-370.
85. MS Dorreen, GW Pennington, DR Millar, et al. (1988) Results of low-dose methotrexate treatment of persistent gestational trophoblastic disease in Sheffield 1980-1987. Acta Oncol 27 551-556.
86. KD Bagshawe, J Dent, ES Newlands, et al. (1989) The role of low dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT). Br J Obstet Gynaecol 96 795-802.
87. MS Hoffman, JV Fiorica, NC Gleeson, et al. (1996) A single institution experience with weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. Gynecol Oncol 60 292-294.
88. EI Kohorn (2002) Is lack of response to single-agent chemotherapy in gestational trophoblastic disease associated with dose scheduling or chemotherapy resistance? Gynecol Oncol 85 36-39.
89. R Osathanondh, DP Goldstein and GB Pastorfide (1975) Actinomycin D as the primary agent for gestational trophoblastic disease. Cancer 36 863-866.
90. LB Twiggs (1983) Pulse actinomycin D scheduling in nonmetastatic gestational trophoblastic neoplasia: Cost-effective chemotherapy. Gynecol Oncol 16 190-195.
91. ES Petrilli, LB Twiggs, JA Blessing, et al. (1987) Single-dose actinomycin-D treatment for nonmetastatic gestational trophoblastic disease. A prospective phase II trial of the Gynecologic Oncology Group. Cancer 60 2173-2176.
92. ES Newlands, L Holden, MJ Seckl, et al. (2002) Management of brain metastases in patients with high-risk gestational trophoblastic tumors. J Reprod Med 47 465-471.
93. G Bolis, C Bonazzi, F Landoni, et al. (1988) EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT). Gynecol Oncol 31 439-444.
94. JC Schink, DK Singh, AW Rademaker, et al. (1992) Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vin-cristine for the treatment of metastatic, high-risk gestational trophoblastic disease. Obstet Gynecol 80 817-820.
95. M Quinn, J Murray, M Friedlander, et al. (1994) EMACO in high risk gestational trophoblast disease—the Australian experience. Gestational Trophoblast Subcommittee, Clinical Oncological Society of Australia. Aust N Z J Obstet Gynaecol 34 90-92.
96. SJ Kim, SN Bae, JH Kim, et al. (1998) Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT—25 years' experience of KRI-TRD. Int J Gynaecol Obstet 60(Suppl 1), S85-S96.
97. JR Lurain (1998) Management of high-risk gestational trophoblastic disease. J Reprod Med 43 44-52.
98. Y Xiang, X Yang and S Han (1999) [Methotrexate combined chemotherapy for chemorefractory gestational trophoblastic tumor]. Zhonghua Fu Chan Ke Za Zhi 34 97-100.
99. LS Dobson, PC Lorigan, RE Coleman and BW Hancock (2000) Persistent gestational trophoblastic disease: Results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease. Br J Cancer 82 1547-1552.
100. H Matsui, K Suzuka, Y Iitsuka, et al. (2000) Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors. Gynecol Oncol 78 28-31.
101. C Boshoff, RH Begent, RT Oliver, et al. (1995) Secondary tumours following etoposide containing therapy for germ cell cancer. Ann Oncol 6 35-40.
102. ES Newlands, PJ Mulholland, L Holden, et al. (2000) Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol 18 854-859.
103. AN Gordon, JJ Kavanagh, DM Gershenson, et al. (1986) Cisplatin, vinblastine, and bleomycin combination therapy in resistant gestational trophoblastic disease. Cancer 58 1407-1410.
104. B DuBeshter, RS Berkowitz, DP Goldstein and M Bernstein (1989) Vinblastine, cisplatin and bleomycin as salvage therapy for refractory high-risk metastatic gestational trophoblastic disease. J Reprod Med 34 189-192.
105. M Azab, JP Droz, C Theodore, et al. (1989) Cisplatin, vinblastine, and bleomycin combination in the treatment of resistant high-risk gestational trophoblastic tumors. Cancer 64 1829-1832.
106. RJ Motzer, DF Bajorin, LH Schwartz, et al. (1994) Phase II trial of pacli-taxel shows antitumour activity in patients with previously treated germ cell tumours. J Clin Oncol 12 2277-2283.
107. WB Jones, J Schneider, F Shapiro and JLJ Lewis (1996) Treatment of resistant gestational choriocarcinoma with taxol: A report of two cases. Gynaecol Oncol 61 126-130.
108. R Gerson, A Serrano, M Del Carmen Bello, et al. (1997) Response of choriocarcinoma to paclitaxel. Case report and review of resistance. Eur J Gynaecol Oncol 18 108-110.
109. W Termrungruanglert, AP Kudelka, S Piamsomboon, et al. (1996) Remission of refractory gestational trophoblastic disease with high-dose paclitaxel. Anticancer Drugs 7 503-506.
110. J Beyer, A Kramar, R Mandanas, et al. (1996) High-dose chemotherapy as salvage treatment in germ cell tumors: A multivariate analysis of prognostic variables. J Clin Oncol 14 2638-2645.
111. MP Lyttelton, ES Newlands, C Giles, et al. (1998) High-dose therapy including carboplatin adjusted for renal function in patients with relapsed germ cell tumor: Outcome and prognostic factors. Br J Cancer 77 1672-1676.
112. PL Giacalone, P Benos, D Donnadio and F Laffargue (1995) High-dose chemotherapy with autologous bone marrow transplantation for refractory metastatic gestational trophoblastic disease. Gynaecol Oncol 58 383-385.
113. K van Besien, C Verschraegen, R Mehra, et al. (1997) Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin and etoposide (ICE) and stem cell rescue. Gynaecol Oncol 65 366-369.
114. S Knox, SE Brooks, J Wong-You-Cheong, et al. (2002) Choriocarcinoma and epithelial trophoblastic tumor: Successful treatment of relapse with hysterectomy and high-dose chemotherapy with peripheral stem cell support: A case report. Gynecol Oncol 85 204-208.
115. MP Kelly, GJS Rustin, C Ivory, et al. (1990) Respiratory failure due to choriocarcinoma: A study of 103 dyspneic patients. Gynaecol Oncol 38 149-154.
116. A Athanassiou, RHJ Begent, ES Newlands, et al. (1983) Central nervous system metastases of choriocarcinoma: 23 years' experience at Charing Cross Hospital. Cancer 52 1728-1735.
117. SK Lo, JN Montgomery, S Blagden, et al. (1999) Reducing incidence of headache after lumbar puncture and intrathecal cytotoxics. Lancet 353 2038-2039.
118. AM Gillespie, N Siddiqui, RE Coleman and BW Hancock (1999) Gestational trophoblastic disease: Does central nervous system chemoprophylaxis have a role? Br J Cancer 79 1270-1272.
119. T Ishizuka (1983) Intracranial metastases of choriocarcinoma: A clinicopathologic study. Cancer 52 1896-1903.
120. HZ Song and PC Wu (1988) Treatment of brain metastases in choriocarcinoma and invasive mole. HZ Song, PC Wu (Eds) Studies in Trophoblastic Disease in China Oxford: Pergamon 231-237.
121. GJS Rustin, ES Newlands, RHJ Begent, et al. (1989) Weekly alternating chemotherapy (EMA/CO) for treatement of central nervous systems of choriocarcinoma. J Clin Oncol 7 900-903.
122. A Altintas and MA Vardar (2001) Central nervous system involvement in gestational trophoblastic neoplasia. Eur J Gynaecol Oncol 22 154-156.
123. W Small Jr, JR Lurain, RM Shetty, et al. (1996) Gestational trophoblastic disease metastatic to the brain. Radiology 200 277-280.
124. NR Schechter, B Mychalczak, W Jones and D Spriggs (1998) Prognosis of patients treated with whole-brain radiation therapy for metastatic gestational trophoblastic disease. Gynecol Oncol 68 183-192.
125. CM Feltmate, DR Genest, DP Goldstein and RS Berkowitz (2002) Advances in the understanding of placental site trophoblastic tumor. J Reprod Med 47 337-341.
126. MP Hopkins, CW Drescher, A McQuillan, et al. (1992) Malignant placental site trophoblastic tumour associated with placental abruption, fetal distress, and elevated CA-125. Gynecol Oncol 47 267-271.
127. SP Blagden, MA Foskett, RA Fisher, et al. (2002) The effect of early pregnancy following chemotherapy on disease relapse and foetal outcome in women treated for gestational trophoblastic tumours. Br J Cancer 86 26-30.
128. MJ Ratain, LS Kaminer, JD Bitran, et al. (1987) Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung. Blood 70 1192-1196.
129. JA Whitlock, JP Greer and JN Lukens (1991) Epipodophyllotoxin-related leukaemia. Identification of a new subset of secondary leukaemia. Cancer 68 600-604.
130. CH Pui, RC Ribeiro, ML Hancock, et al. (1991) Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lym-phoblastic lymphoma. N Engl J Med 325 1682-1687.
131. RP Woolas, M Bower, ES Newlands, et al. (1998) Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome. Br J Obstet Gynaecol 105 1032-1035.
132. M Bower, GJS Rustin, ES Newlands, et al. (1998) Chemotherapy for gestational trophoblastic tumours hastens menopause by 3 years. Eur J Cancer 34 1204-1207.
133. HYS Ngan and GWK Tang (1986) Psychosocial aspects of gestational trophoblastic disease in Chinese residents of Hong Kong. J Reprod Med 31 173-178.
134. L Wenzel, R Berkowitz, ES Newlands, et al. (2002) Quality of life after gestational trophoblastic disease. J Reprod Med 47 387-394.
135. MO Mundinger, RL Kane, ER Lenz, et al. (2000) Primary care outcomes in patients treated by nurse practitioners or physicians: A randomized trial. JAMA 283 59-68.
136. LA Loftus and V Weston (2001) The development of nurse-led clinics in cancer care. J Clin Nurs 10 215-220.
137. ES Newlands, KD Bagshawe, RHJ Begent, et al. (1986) Development of chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979-1984). Br J Obstet Gynaecol 93 63-69.
138. SL Curry, CB Hammond, L Tyrey, WT Creasman, et al. (1975) Hydatidiform moles, diagnosis management and long term follow-up of 347 patients. Obstet Gynaecol 45 1-8.
139. X Zongfu, S Hongzhao and T Minyi (1979) Risk of malignancy and prognosis using a provisional scoring system in hydatidiform mole. China Med J 93 605-612.